Pharmaceutical / Drug Definition :
Dilates pulmonary and systemic arterial vascular beds, reducing right and left ventricular afterload and increasing cardiac output and stroke volume. Also inhibits platelet aggregation
FDA Label Requirements and Exceptions
Treprostinil Sodium
FDA Import Information
Treprostinil Sodium
FDA Detentions
Treprostinil Sodium (Treprostinil Sodium Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Treprostinil Sodium (Treprostinil Sodium Suppliers)
- Processors Treprostinil Sodium
- Repackers Treprostinil Sodium
- Relabelers Treprostinil Sodium
- Exporters Treprostinil Sodium
- Importers Treprostinil Sodium
For more information about Treprostinil Sodium, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
